The Strategist

The long-term impact of Change hack, plus GLP-1s expand to CV

Posted By The Academy

March 21, 2024

This issue of The Strategist includes:

1. Change is finally back online, as health systems assess fallout

2. FDA approval and new partnerships expand reach of GLP-1 drugs

3. Mark Cuban Cost Plus Drugs partners with CHS

The Strategist 21 Ma R24.pdf